According to the study’s, prior COVID-19 infection seems to have no effect on a woman’s probability of success with assisted reproductive technologies. Although the research is tiny, it allays some fears about the virus’s effect on fertility. The researchers reviewed data from 46 patients undergoing in vitro fertilization (IVF) who had baseline anti-Mullerian hormone (AMH) levels consistent with normal or low ovarian stimulation response.
AMH levels were stable between before and after a lady was infected with SARS-CoV-2, the virus that causes COVID-19. The results indicated a little drop in AMH levels in a sample of patients expected to respond normally to ovarian stimulation. The research concluded that intrauterine infection through placental or congenital pathways was improbable and that any newborn infection was more likely to be caused by perinatal infection discovered during and after birth. When therapy started, it seemed as if they would be normal or modest responders to ovarian stimulation.
